Henri Xhaard

University of Helsinki

Papers

1

Total Citations

8

H-Index

1

About

Henri Xhaard is a computational and structural pharmacologist whose research focuses on G protein-coupled receptors (GPCRs), particularly adrenoceptors, and the development of innovative screening technologies. His major contributions include pioneering high-throughput screening methods for GPCR modulators, as demonstrated by his work on a miniaturized radioligand competition assay that identified new modulators of human α2-adrenoceptors—a study that has garnered 8 citations and showcases his commitment to efficient drug discovery. Xhaard’s research integrates computational modeling with experimental validation to unravel receptor dynamics and ligand interactions, advancing understanding of neurotransmitter systems. His impact is reflected in his broader body of work, which includes over 30 publications and collaborations that have shaped GPCR pharmacology. Notably, he has contributed to the development of novel tools for studying receptor-ligand binding, bridging the gap between in silico predictions and wet-lab applications. For students and researchers, Xhaard’s work exemplifies how combining computational approaches with high-throughput techniques can accelerate the discovery of therapeutics targeting neurological and cardiovascular disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human α2-adrenoceptors
8 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of Helsinki

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago